semaglutide addiction clinical trials Two-year effects of in adults with overweight or obesity: the STEP 5 trial In the original clinical trials

One of our most innovative products, these Self-Dissolving Microneedle Patches directly deliver active ingredients onto skin's surface layers that are often difficult to absorb

Secondary outcomes included the incidence of aborted EGDs due to GRC, the effect of concurrent CLN on GRC, and a comparison of GRC risk among different GLP-1 RA agents

New NIH research reveals that semaglutide sparks different responses inside appetite-controlling brain cells, offering fresh insight into why GLP-1 weight-loss drugs dont work the same for everyone

Vaginal symptoms are common and usually not dangerous, but they can be uncomfortable, and misinterpreting them can lead to delays in effective treatment

GLP-1 drugs like Ozempic may reduce bone density

Biohaven highlights opakalim seizure-control data, Phase 1b results for Graves and IgA nephropathy degraders, and early PKM2 activator safety as several programs advance toward pivotal trials.